A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4545 (2006.01) A61K 9/24 (2006.01) A61K 31/137 (2006.01) A61K 31/445 (2006.01) A61P 11/02 (2006.01) A61P 37/08 (2006.01)
Patent
CA 2329217
A film-coated extended release solid oral dosage composition containing a nasal decongestant, pseudoephedrine or salt thereof, e.g., pseudoephedrine sulfate in a core effective to provide a geometric maximum plasma concentration of pseudoephedrine of about 345 ng/mL to about 365 ng/mL at a time of about 7.60 hrs to about 8.40 hrs and having two or three film-coatings on thecore, the second one containing an amount of the non-sedating antihistamine, desloratadine, effective to provide a geometric maximum plasma concentration of desloratadine of about 2.15 ng/mL to about 2.45 ng/mL at a time of about 4.0 hours to about 4.5 hours, and use of the composition for treating patients showing the signs and symptoms associated with allergic and/or inflammatory conditions of the skin and airway passages are disclosed.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Stable extended release oral dosage composition comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable extended release oral dosage composition comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable extended release oral dosage composition comprising... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1969495